Abstract

关键词: YTHDF3, 肿瘤, 作用机制, 肿瘤靶点

CLC Number:

R730

周涛, 孙雨, 唐熙峻, 郑帅, 赵恩宏, 肖丽君. YTHDF3在肿瘤中的作用及研究进展[J]. 承德医学院学报, 2025, 42(4): 320-324.

Add to citation manager EndNote|Ris|BibTeX

URL: http://tougao.cdmc.edu.cn:8088/EN/

http://tougao.cdmc.edu.cn:8088/EN/Y2025/V42/I4/320

[1] Roignant J, Soller M. m6A in mRNA: An Ancient Mechanism for Fine-Tuning Gene Expression[J]. Trends in Genetics, 2017, 33(6): 380-390.
[2] Zhang G, Hou J, Mei C, et al.Effect of circular RNAs and N6-methyladenosine (m6A) modification on cancer biology[J]. Biomed Pharmacother, 2023, 159: 114260.
[3] Li A, Chen YS, Ping XL, et al.Cytoplasmic m6A reader YTHDF3 promotes mRNA translation[J]. Cell Research, 2017, 27(3): 444-447.
[4] Huang HL, Weng HY, Sun WJ, et al.Recognition of RNA N6-methyladenosine by IGF2BP proteins enhances mRNA stability and translation[J]. Nature Cell Biology, 2018, 20(3): 285-295.
[5] Shi HL, Wang X, Lu Z, et al.YTHDF3 facilitates translation and decay of N6-methyladenosine-modified RNA[J]. Cell Research, 2017, 27(3): 315-328.
[6] Hao WC, Dian MJ, Zhou Y, et al.Autophagy induction promoted by m6A reader YTHDF3 through translation upregulation of FOXO3 mRNA[J]. Nature Communications, 2022, 13(1): 5845.
[7] Yang Y, Fan XJ, Mao MW, et al.Extensive translation of circular RNAs driven by N6-methyladenosine[J]. Cell Research, 2017, 27(5): 626-641.
[8] 董政,谭谦. RNA甲基化修饰N6-甲基腺苷在黑色素瘤预后及免疫微环境中的作用[J]. 中国美容整形外科杂志,2022,33(12):729-733,774.
[9] Shi HZ, Xiong JS, Gan L, et al.N6-methyladenosine reader YTHDF3 regulates melanoma metastasis via its 'executor'LOXL3[J]. Clin Transl Med, 2022, 12(11): e1075.
[10] Xu Y, He X, Wang S, et al.The m6A reading protein YTHDF3 potentiates tumorigenicity of cancer stem-like cells in ocular melanoma through facilitating CTNNB1 translation[J]. Oncogene, 2022, 41(9): 1281-1297.
[11] Liu J, Zhu J, Wang X, et al.A Novel YTHDF3-Based Model to Predict Prognosis and Therapeutic Response in Breast Cancer[J]. Front Mol Biosci, 2022, 9: 874532.
[12] Zhang B, Gu Y, Jiang G.Expression and Prognostic Characteristics of m6A RNA Methylation Regulators in Breast Cancer[J]. Front Genet, 2020, 11: 604597.
[13] Ramesh A, Arumugam P, Vijayashree JP, et al.The m6A readers iYTHDF1/i and iYTHDF3/i aberrations associated with metastasis and predict poor prognosis in breast cancer patients[J]. American Journal of Cancer Research, 2020, 10(8): 2546-2554.
[14] 龚荣府. YTHDF3通过m6A甲基化调控乳腺癌细胞生物学行为的机制初探[D]. 贵阳:贵州医科大学,2022.
[15] Liu M, Zhou S, Wang J, et al.Identification of genes associated with survival of breast cancer patients[J]. Breast Cancer, 2019, 26(3): 317-325.
[16] Lin YX, Jin X, Nie Q, et al.YTHDF3 facilitates triple-negative breast cancer progression and metastasis by stabilizing ZEB1 mRNA in an m6A-dependent manner[J]. Annals of Translational Medicine, 2022, 10(2): 83.
[17] 胡宽,姚磊,李娟妮. YTH基因家族在肝癌中的表达和预后价值[J]. 中国普通外科杂志,2021,30(7):836-846.
[18] Guo JC, Liu Z, Yang YJ, et al.KDM5B promotes self-renewal of hepatocellular carcinoma cells through the microRNA-448-mediated YTHDF3/ITGA6 axis[J]. J Cell Mol Med, 2021, 25(13): 5949-5962.
[19] Zhou R, Ni W, Qin C, et al.A functional loop between YTH domain family protein YTHDF3 mediated m6A modification and phosphofructokinase PFKL in glycolysis of hepatocellular carcinoma[J]. J Exp Clin Cancer Res, 2022,41(1): 334.
[20] Wang M, Yang Y, Yang J, et al.circ_KIAA1429 accelerates hepatocellular carcinoma advancement through the mechanism of m6A-YTHDF3-Zeb1[J]. Life Sci, 2020, 257: 118082.
[21] Chen S, Wang L, Xu Z, et al.YTHDF3-mediated m6A modification of NKD1 regulates hepatocellular carcinoma invasion and metastasis by activating the WNT/β-catenin signaling axis[J]. Experimental Cell Research, 2024, 442(1): 114192.
[22] Hu YH, Tang J, Xu FY, et al.A reciprocal feedback between N6-methyladenosine reader YTHDF3 and lncRNA DICER1-AS1 promotes glycolysis of pancreatic cancer through inhibiting maturation of miR-5586-5p[J]. Journal of Experimental Clinical Cancer Research, 2022, 41(1): 69.
[23] Zhang H, Sun Y, Wang ZK, et al.ZDHHC20-mediated S-palmitoylation of YTHDF3 stabilizes MYC mRNA to promote pancreatic cancer progression[J]. Nature Communications, 2024, 15(1): 4642.
[24] Zhou Y, Zhuang HR, Liu YX, et al.Celastrol suppresses human pancreatic cancer via m6A-YTHDF3-mediated downregulation of Claspin and Bcl-2[J]. Discov Oncol, 2023, 14(1): 233.
[25] Liu DY, Li Z, Zhang K, et al.N6-methyladenosine reader YTHDF3 contributes to the aerobic glycolysis of osteosarcoma through stabilizing PGK1 stability[J]. Journal of Cancer Research and Clinical Oncology, 2022, 149(8): 4601-4610.
[26] Jin D, Guo JW, Wu Y, et al.Correction: m6A demethylase ALKBH5 inhibits tumor growth and metastasis by reducing YTHDFs-mediated YAP expression and inhibiting miR-107/LATS2-mediated YAP activity in NSCLC[J]. Mol Cancer, 2022, 21(1): 130.
[27] Xu Y, Chen Y, Yao Y, et al.VIRMA contributes to non-small cell lung cancer progression via N6-methyladenosine-dependent DAPK3 post-transcriptional modification[J]. Cancer Lett, 2021, 522: 142-154.
[28] Jin D, Guo JW, Wu Y, et al.m6A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis[J]. Journal of Hematology Oncology, 2021, 14(1): 32.
[29] Wang P, Wang X, Zheng L, et al.Gene Signatures and Prognostic Values of m6A Regulators in Hepatocellular Carcinoma[J]. Front Genet, 2020, 11: 540186.
[30] Zhao Y, Huang SY, Tan XR, et al.Nsup6/sup -Methyladenosine-Modified CBX1 Regulates Nasopharyngeal Carcinoma Progression Through Heterochromatin Formation and STAT1 Activation[J]. Advanced Science (Weinh), 2022, 9(36): e2205091.
[31] Jin H, Ying XL, Que B, et al.N6-methyladenosine modification of ITGA6 mRNA promotes the development and progression of bladder cancer[J]. Ebio Medicine, 2019, 47: 195-207.
[32] Qiu DD, Gao LL, Yu XW.Knockdown of YAP1 Reduces YTHDF3 to Stabilize SMAD7 and thus Inhibit Bladder Cancer Stem Cell Stemness[J]. Discov Med, 2024, 36(186): 1486-1498.
[33] Ni W, Yao S, Zhou YX, et al.Long noncoding RNA GAS5 inhibits progression of colorectal cancer by interacting with and triggering YAP phosphorylation and degradation and is negatively regulated by the msup6/supA reader YTHDF3[J]. Molecular Cancer, 2019, 18(1): 143.
[34] Duan JJ, Fan DG, Chen PP, et al.YTHDF3 Regulates the Degradation and Stability of m6A-Enriched Transcripts to Facilitate the Progression of Castration-Resistant Prostate Cancer[J]. J Pineal Res, 2024, 76(5): e13003.

YTHDF3在肿瘤中的作用及研究进展

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 10

Recommended Articles

Metrics

Comments

[1]	. [J]. Journal of Chengde Medical University, 2025, 42(1): 57-60.
[2]	. [J]. Journal of Chengde Medical University, 2024, 41(5): 413-417.
[3]	. [J]. Journal of Chengde Medical University, 2024, 41(3): 244-248.
[4]	. [J]. Journal of Chengde Medical University, 2023, 40(6): 480-483.
[5]	. [J]. Journal of Chengde Medical University, 2022, 39(5): 424-427.
[6]	. [J]. Journal of Chengde Medical University, 2020, 37(6): 521-521.
[7]	. [J]. Journal of Chengde Medical University, 2020, 37(4): 330-332.
[8]	. [J]. Journal of Chengde Medical University, 2020, 37(3): 244-246.
[9]	. [J]. Journal of Chengde Medical University, 2018, 35(6): 519-521.
[10]	. [J]. Journal of Chengde Medical University, 2017, 34(4): 336-339.